FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q2 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.
... More
